Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Distribution

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody`s analgesic powders, Boudreaux`s Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden`s cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer`s Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Website: prestigebrands.com


  • Bad financial results growth rate -4.5% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (0.1%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 4.1% (LTM)
  • Share price is 8.8% higher than minimum and 31.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (10.9x vs 30.0x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.2 mln (-0.008% of cap.)

Key Financials (Download financials)

Ticker: PBH
Share price, USD:  (0.0%)61.22
year average price 73.64  


year start price 74.00 2025-01-12

max close price 89.09 2025-05-16

min close price 57.47 2025-11-24

current price 61.22 2026-01-11
Common stocks: 49 025 000

Dividend Yield:  0.0%
FCF Yield LTM: 4.1%
EV / LTM EBITDA: 10.9x
EV / EBITDA annualized: 11.3x
Last revenue growth (y/y):  -3.5%
Last growth of EBITDA (y/y):  -5.4%
Historical revenue growth:  +0.1%
Historical growth of EBITDA:  0.0%
EV / Sales: 3.5x
Margin (EBITDA LTM / Revenue): 32.5%

Target EV / EBITDA (hist percentile): 30.0x
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 3 001
Net Debt ($m): 937
EV (Enterprise Value): 3 938
EBITDA LTM (млн $): 361
EV / LTM EBITDA: 10.9x
Price to Book: 1.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-02zacks.com

Is This the Right Time to Add PBH Stock to Your Portfolio?

2025-12-17zacks.com

PBH vs. ABT: Which Stock Should Value Investors Buy Now?

2025-12-01zacks.com

PBH or ABT: Which Is the Better Value Stock Right Now?

2025-11-06seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript

2025-10-06globenewswire.com

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

2025-09-05seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript

2025-08-25seekingalpha.com

Premium Brands: Long Climb To $10 Billion

2025-08-08seekingalpha.com

Prestige Consumer Healthcare Inc. (PBH) Q1 2026 Earnings Call Transcript

2025-08-07globenewswire.com

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results

2025-06-30zacks.com

Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-15 2024-02-08 2023-11-02 2023-08-03 2023-05-05 2023-02-02 2022-11-03
acceptedDate 2025-11-06 06:11:07 2025-08-07 06:15:06 2024-11-07 06:11:01 2024-08-08 06:10:00 2024-05-15 07:01:05 2024-02-08 06:10:27 2023-11-02 06:11:44 2023-08-03 06:27:14 2023-05-05 16:08:25 2023-02-02 06:11:42 2022-11-03 06:37:20
calendarYear 2026 2026 2025 2025 2024 2024 2024 2024 2023 2023 2023
period Q2 Q1 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
revenue 274M 250M 284M 267M 277M 283M 286M 279M 286M 276M 289M
costOfRevenue 120M 114M 126M 127M 131M 125M 126M 125M 132M 125M 128M
grossProfit 154M 135M 157M 140M 146M 158M 160M 155M 154M 150M 161M
grossProfitRatio 0.562 0.542 0.555 0.525 0.528 0.559 0.559 0.554 0.538 0.546 0.557
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 28M 28M 26M 29M 26M 26M 26M 28M 28M 27M 26M
sellingAndMarketingExpenses 39M 35M 41M 39M 38M 39M 40M 36M 31M 30M 44M
sellingGeneralAndAdministrativeExpenses 67M 63M 67M 68M 64M 65M 66M 64M 59M 57M 70M
otherExpenses 8M 0 6M -496 000 429 000 -682 000 -229 000 1M 6M 6M 6M
operatingExpenses 74M 63M 73M 68M 64M 71M 72M 69M 65M 63M 77M
costAndExpenses 194M 178M 199M 195M 195M 196M 198M 194M 197M 188M 205M
interestIncome 0 0 0 0 0 17M 18M 0 0 0 0
interestExpense 10M 10M 12M 13M 15M 17M 18M 18M 19M 18M 17M
depreciationAndAmortization 8M 8M 6M 8M 8M 8M 6M 8M 6M 7M 7M
ebitda 87M 80M 90M 80M 90M 94M 94M 94M 96M 94M 92M
ebitdaratio 0.317 0.319 0.316 0.3 0.325 0.332 0.327 0.336 0.335 0.342 0.317
operatingIncome 80M 72M 84M 72M 82M 87M 88M 85M 90M 87M 84M
operatingIncomeRatio 0.291 0.288 0.297 0.27 0.297 0.307 0.308 0.305 0.314 0.316 0.292
totalOtherIncomeExpensesNet -11M -10M -13M -14M -15M -682 000 -229 000 1M -389M -19M -18M
incomeBeforeTax 69M 62M 72M 58M 67M 70M 70M 69M -300M 68M 67M
incomeBeforeTaxRatio 0.252 0.248 0.253 0.219 0.243 0.246 0.246 0.246 -1.048 0.247 0.23
incomeTaxExpense 27M 14M 17M 9M 18M 17M 17M 15M -59M 16M 16M
netIncome 42M 47M 54M 49M 49M 53M 54M 53M -241M 52M 51M
netIncomeRatio 0.154 0.19 0.192 0.184 0.179 0.188 0.187 0.191 -0.841 0.189 0.176
eps 0.86 0.96 1.1 0.98 0.99 1.07 1.08 1.07 -4.83 1.05 1.02
epsdiluted 0.86 0.95 1.09 0.98 0.98 1.06 1.07 1.06 -4.83 1.04 1.02
weightedAverageShsOut 49M 49M 50M 50M 50M 50M 50M 50M 50M 50M 50M
weightedAverageShsOutDil 49M 50M 50M 50M 50M 50M 50M 50M 50M 50M 50M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-15 2024-02-08 2023-11-02 2023-08-03 2023-05-05 2023-02-02 2022-11-03
acceptedDate 2025-11-06 06:11:07 2025-08-07 06:15:06 2024-11-07 06:11:01 2024-08-08 06:10:00 2024-05-15 07:01:05 2024-02-08 06:10:27 2023-11-02 06:11:44 2023-08-03 06:27:14 2023-05-05 16:08:25 2023-02-02 06:11:42 2022-11-03 06:37:20
calendarYear 2026 2026 2025 2025 2024 2024 2024 2024 2023 2023 2023
period Q2 Q1 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 119M 140M 52M 34M 46M 64M 60M 55M 58M 86M 42M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 119M 140M 52M 34M 46M 64M 60M 55M 58M 86M 42M
netReceivables 199M 168M 164M 172M 177M 174M 158M 158M 167M 157M 146M
inventory 159M 153M 156M 152M 139M 149M 161M 170M 162M 159M 141M
otherCurrentAssets 20M 19M 9M 11M 13M 7M 8M 9M 4M 7M 8M
totalCurrentAssets 497M 481M 381M 369M 375M 394M 388M 392M 392M 409M 337M
propertyPlantEquipmentNet 122M 125M 84M 86M 89M 83M 86M 87M 90M 91M 93M
goodwill 528M 528M 529M 528M 528M 528M 527M 527M 528M 577M 576M
intangibleAssets 2 291M 2 295M 2 317M 2 318M 2 321M 2 329M 2 328M 2 336M 2 342M 2 670M 2 671M
goodwillAndIntangibleAssets 2 819M 2 823M 2 846M 2 846M 2 848M 2 856M 2 855M 2 864M 2 869M 3 247M 3 247M
longTermInvestments 0 0 0 -409M -404M -397M -388M -384M 0 0 0
taxAssets 0 0 0 409M 38M 397M 388M 384M 380M 456M 0
otherNonCurrentAssets 3M 3M 7M 6M 409M 6M 4M 3M -377M -453M 3M
totalNonCurrentAssets 2 945M 2 951M 2 936M 2 939M 2 982M 2 946M 2 945M 2 954M 2 962M 3 341M 3 342M
otherAssets 0 0 0 0 1 0 0 0 0 0 0
totalAssets 3 442M 3 432M 3 317M 3 308M 3 357M 3 340M 3 333M 3 346M 3 354M 3 750M 3 679M
accountPayables 42M 22M 31M 40M 39M 39M 44M 58M 63M 64M 56M
shortTermDebt 9M 9M 3M 9M 6M 8M 10M 9M 10M 10M 9M
taxPayables 0 5M 104 000 189 000 3M 6M 8M 10M 11M 7M 12M
deferredRevenue 0 0 0 189 000 3M 0 0 0 0 0 0
otherCurrentLiabilities 84M 73M 73M 65M 69M 80M 76M 80M 88M 86M 87M
totalCurrentLiabilities 135M 110M 107M 114M 117M 127M 130M 147M 161M 160M 152M
longTermDebt 1 032M 1 034M 1 058M 1 098M 1 126M 1 206M 1 270M 1 326M 1 357M 1 438M 1 454M
deferredRevenueNonCurrent 0 0 0 7M 46M 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 427M 0 409M 442M 397M 388M 384M 380M 456M 443M
otherNonCurrentLiabilities 450M 5M 420M 5M -29M 9M 9M 8M 8M 9M 1 841M
totalNonCurrentLiabilities 1 483M 1 466M 1 478M 1 513M 1 585M 1 612M 1 667M 1 718M 1 746M 1 903M 1 906M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 48M 50M 9M 12M 8M 14M 16M 19M 21M 24M 25M
totalLiabilities 1 617M 1 576M 1 585M 1 627M 1 702M 1 739M 1 797M 1 865M 1 907M 2 063M 2 059M
preferredStock 0 0 0 0 0 0 0 0 0 0 0
commonStock 562 000 561 000 0 557 000 555 000 553 000 552 000 552 000 548 000 548 000 547 000
retainedEarnings 1 645M 1 603M 1 445M 1 390M 1 341M 1 292M 1 239M 1 185M 1 132M 1 372M 1 320M
accumulatedOtherComprehensiveIncomeLoss -32M -32M -27M -31M -34M -29M -36M -32M -32M -29M -36M
othertotalStockholdersEquity 211M 284M 314M 321M 348M 337M 333M 327M 346M 343M 335M
totalStockholdersEquity 1 825M 1 855M 1 732M 1 681M 1 655M 1 601M 1 536M 1 480M 1 447M 1 687M 1 620M
totalEquity 1 825M 1 855M 1 732M 1 681M 1 655M 1 601M 1 536M 1 480M 1 447M 1 687M 1 620M
totalLiabilitiesAndStockholdersEquity 3 442M 3 432M 3 317M 3 308M 3 357M 3 340M 3 333M 3 346M 3 354M 3 750M 3 679M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 3 442M 3 432M 3 317M 3 308M 3 357M 3 340M 3 333M 3 346M 3 354M 3 750M 3 679M
totalInvestments 0 0 0 -409M -404M -397M -388M -384M 0 0 0
totalDebt 1 041M 1 043M 1 061M 1 103M 1 140M 1 214M 1 279M 1 335M 1 367M 1 448M 1 464M
netDebt 922M 903M 1 009M 1 069M 1 093M 1 150M 1 219M 1 281M 1 309M 1 361M 1 421M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH PBH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-07 2024-08-08 2024-05-15 2024-02-08 2023-11-02 2023-08-03 2023-05-05 2023-02-02 2022-11-03
acceptedDate 2025-11-06 06:11:07 2025-08-07 06:15:06 2024-11-07 06:11:01 2024-08-08 06:10:00 2024-05-15 07:01:05 2024-02-08 06:10:27 2023-11-02 06:11:44 2023-08-03 06:27:14 2023-05-05 16:08:25 2023-02-02 06:11:42 2022-11-03 06:37:20
calendarYear 2026 2026 2025 2025 2024 2024 2024 2024 2023 2023 2023
period Q2 Q1 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
netIncome 42M 47M 54M 49M 49M 53M 54M 53M -241M 52M 51M
depreciationAndAmortization 8M 8M 8M 8M 8M 8M 8M 8M 8M 8M 8M
deferredIncomeTax 17M 6M -612 000 612 000 8M 5M 5M 4M -75M 10M 3M
stockBasedCompensation 0 4M 2M 3M 4M 2M 4M 4M 3M 2M 3M
changeInWorkingCapital -14M 12M -622 000 -9M -6M 18 000 -11M -23M -10M -20M -11M
accountsReceivables -30M 27M 9M 6M 695 000 -11M -1M 6M -8M -9M -1M
inventory -6M -4M -3M -13M 11M 14M 8M -8M -4M -17M -7M
accountsPayables 20M 3M -8M 591 000 -1M -5M -13M -6M -2M 8M -2M
otherWorkingCapital 2M -14M 2M -3M -16M 3M -4M -16M 3M -2M -620 000
otherNonCashItems 4M 2M 7M 28M 12M 3M 3M 2M 374M 3M 3M
netCashProvidedByOperatingActivities 57M 79M 70M 55M 67M 71M 62M 48M 59M 55M 58M
investmentsInPropertyPlantAndEquipment -2M -838 000 -2M -1M -3M -2M -3M -1M -3M -2M -2M
acquisitionsNet 0 0 0 0 -11M 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -827 000 -1M 0 -978 000 -12M -3M 0 4M -4M 0 0
netCashUsedForInvestingActivites -3M -2M -2M -2M -15M -4M -3M 2M -6M -2M -2M
debtRepayment -539 000 -608 000 -41M -36M -76M -66M -56M -31M -81M -16M -36M
commonStockIssued 752 000 0 0 0 7M 2M 2M 0 7M 0 0
commonStockRepurchased -75M -35M -12M -26M 0 0 0 -25M 0 0 -12M
dividendsPaid 0 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites -162 000 -899 000 2M -4M 7M -769 000 2M 2M -7M 6M 0
netCashUsedProvidedByFinancingActivities -75M -36M -51M -66M -68M -65M -54M -54M -80M -10M -48M
effectOfForexChangesOnCash -4000 825 000 711 000 663 000 -605 000 1M -490 000 -140 000 -3000 798 000 -635 000
netChangeInCash -20M 42M 17M -12M -17M 4M 5M -4M -28M 44M 7M
cashAtEndOfPeriod 119M 140M 52M 34M 46M 64M 60M 55M 58M 86M 42M
cashAtBeginningOfPeriod 140M 98M 34M 46M 64M 60M 55M 58M 86M 42M 36M
operatingCashFlow 57M 79M 70M 55M 67M 71M 62M 48M 59M 55M 58M
capitalExpenditure -2M -838 000 -2M -1M -3M -2M -3M -1M -3M -2M -2M
freeCashFlow 55M 78M 68M 54M 64M 69M 60M 47M 56M 53M 55M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2026 q2)
2025 q2
2025-08-08 ET (fiscal 2026 q1)
2025 q1
2025-05-11 ET (fiscal 2025 q4)
2024 q4
2025-02-06 ET (fiscal 2025 q3)
2024 q3
2024-11-09 ET (fiscal 2025 q2)
2024 q2
2024-08-08 ET (fiscal 2025 q1)
2024 q1
2024-05-15 ET (fiscal 2024 q4)
2023 q4
2024-02-08 ET (fiscal 2024 q3)
2023 q3
2023-11-04 ET (fiscal 2024 q2)
2023 q2
2023-08-05 ET (fiscal 2024 q1)
2023 q1
2023-05-06 ET (fiscal 2023 q4)
2022 q4
2023-02-02 ET (fiscal 2023 q3)
2022 q3
2022-11-06 ET (fiscal 2023 q2)
2022 q2
2022-08-07 ET (fiscal 2023 q1)
2022 q1
2022-05-06 ET (fiscal 2022 q4)
2021 q4
2022-02-03 ET (fiscal 2022 q3)
2021 q2
2021-08-07 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-06 06:11 ET
Prestige Consumer Healthcare reported for 2025 q3
SEC form 8
2025-11-06 06:03 ET
Prestige Consumer Healthcare published news for 2025 q3
SEC form 8
2025-11-06 06:03 ET
Prestige Consumer Healthcare published news for 2025 q3
SEC form 8
2025-11-06 06:03 ET
Prestige Consumer Healthcare published news for 2025 q3
SEC form 10
2025-08-07 10:15 ET
Prestige Consumer Healthcare reported for 2025 q2
SEC form 10
2025-05-09 10:06 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 10
2025-05-09 00:00 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 8
2025-05-08 10:04 ET
Prestige Consumer Healthcare reported for 2025 q1
SEC form 8
2025-05-08 10:04 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 8
2025-05-08 10:04 ET
Prestige Consumer Healthcare published news for 2025 q1
SEC form 10
2025-02-06 06:08 ET
Prestige Consumer Healthcare reported for 2024 q4
SEC form 8
2025-02-06 06:03 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 8
2025-02-06 06:03 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 8
2025-02-06 06:03 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 10
2025-02-06 00:00 ET
Prestige Consumer Healthcare published news for 2024 q4
SEC form 10
2024-11-07 06:11 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 8
2024-11-07 06:03 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 8
2024-11-07 06:03 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 8
2024-11-07 06:03 ET
Prestige Consumer Healthcare published news for 2024 q3
SEC form 10
2024-08-08 06:10 ET
Prestige Consumer Healthcare reported for 2024 q2
SEC form 8
2024-08-08 06:03 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 8
2024-08-08 06:03 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 8
2024-08-08 06:03 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 10
2024-08-08 00:00 ET
Prestige Consumer Healthcare published news for 2024 q2
SEC form 10
2024-05-15 00:00 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-05-14 17:04 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-05-14 17:04 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-05-14 17:04 ET
Prestige Consumer Healthcare published news for 2024 q1
SEC form 8
2024-02-08 00:00 ET
Prestige Consumer Healthcare published news for 2023 q4
SEC form 10
2024-02-08 00:00 ET
Prestige Consumer Healthcare reported for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Prestige Consumer Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Prestige Consumer Healthcare published news for 2023 q4
SEC form 10
2023-11-02 06:11 ET
Prestige Consumer Healthcare reported for 2023 q3
SEC form 8
2023-11-02 06:06 ET
Prestige Consumer Healthcare published news for 2023 q3
SEC form 10
2023-11-02 00:00 ET
Prestige Consumer Healthcare published news for 2023 q3
SEC form 6
2023-08-03 14:00 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 10
2023-08-03 06:27 ET
Prestige Consumer Healthcare reported for 2023 q2
SEC form 6
2023-08-03 06:15 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Prestige Consumer Healthcare published news for 2023 q2
SEC form 6
2023-06-29 16:05 ET
Prestige Consumer Healthcare published news for 2023 q1
SEC form 10
2023-05-05 00:00 ET
Prestige Consumer Healthcare published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Prestige Consumer Healthcare published news for 2023 q1
SEC form 10
2023-02-02 06:11 ET
Prestige Consumer Healthcare reported for 2022 q4
SEC form 6
2023-02-02 06:05 ET
Prestige Consumer Healthcare published news for 2022 q4
SEC form 10
2023-02-02 00:00 ET
Prestige Consumer Healthcare reported for 2022 q4
SEC form 8
2023-02-02 00:00 ET
Prestige Consumer Healthcare reported for 2022 q4
SEC form 10
2022-11-03 06:37 ET
Prestige Consumer Healthcare reported for 2022 q3
SEC form 6
2022-11-03 06:24 ET
Prestige Consumer Healthcare published news for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Prestige Consumer Healthcare reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Prestige Consumer Healthcare reported for 2022 q3
SEC form 10
2022-08-04 06:17 ET
Prestige Consumer Healthcare reported for 2022 q2
SEC form 6
2022-08-04 06:06 ET
Prestige Consumer Healthcare published news for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Prestige Consumer Healthcare reported for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Prestige Consumer Healthcare reported for 2022 q2
SEC form 6
2022-06-28 16:01 ET
Prestige Consumer Healthcare published news for 2022 q1
SEC form 10
2022-05-06 16:20 ET
Prestige Consumer Healthcare reported for 2022 q1
SEC form 10
2022-05-06 00:00 ET
Prestige Consumer Healthcare reported for 2022 q1
SEC form 6
2022-05-05 17:17 ET
Prestige Consumer Healthcare published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Prestige Consumer Healthcare reported for 2022 q1
SEC form 10
2022-02-03 06:26 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 6
2022-02-03 06:04 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 8
2022-02-03 00:00 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 10
2022-02-03 00:00 ET
Prestige Consumer Healthcare published news for 2021 q4
SEC form 10
2021-11-04 06:38 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 6
2021-11-04 06:30 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Prestige Consumer Healthcare published news for 2021 q3
SEC form 10
2021-08-05 06:17 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 6
2021-08-05 06:04 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 6
2021-07-01 16:02 ET
Prestige Consumer Healthcare published news for 2021 q2
SEC form 6
2021-06-29 06:03 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-05-27 17:49 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 10
2021-05-07 16:17 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-05-06 06:44 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-05-05 16:26 ET
Prestige Consumer Healthcare published news for 2021 q1
SEC form 6
2021-03-01 16:15 ET
Prestige Consumer Healthcare published news for 2020 q4
SEC form 10
2021-02-04 06:21 ET
Prestige Consumer Healthcare published news for 2020 q4
SEC form 6
2021-02-04 06:06 ET
Prestige Consumer Healthcare published news for 2020 q4
SEC form 10
2020-11-05 06:14 ET
Prestige Consumer Healthcare published news for 2020 q3
SEC form 6
2020-11-05 06:07 ET
Prestige Consumer Healthcare published news for 2020 q3